A group of 58 specialists from public and private universities advocates for evidence-based regulations for the cultivation and regulation of cannabis in Brazil

Document sets regulatory priorities, including rules for cannabis cultivation, updates to resolutions, and adjustments to the sector's health framework

The regulatory agency published the decision in the Official Gazette of the Union this Monday (8), allowing the inclusion of the dosage of 300 mg/ml

The Brazilian Association of Pharmaceutical Inputs Industry trusts that the request for a view by director Thiago Campos will result in a more in-depth analysis, maintaining the expectation of concluding the regulatory framework in January 2026

The submission of scientific evidence is essential to support the regulation of cannabis cultivation in Brazil and complies with STJ's determination

Rapporteur Rômison Mota advocated for changes impacting imports via RDC 660; new rule prioritizes national products when there is equivalence

Rapporteur Rômison Mota advocated for changes impacting imports via RDC 660; new rule prioritizes national products when there is equivalence

Norm that regulates manufacturing, importation, prescription, and inspection may be entirely revoked and replaced by a new regulatory framework; decision will be made at the Collegiate Board meeting.

Publication in the Official Gazette of this Monday (8) details the approval of the 100 mg/ml oral solution

Draft presents new regulatory framework, tightens requirements for Sanitary Authorization, and prohibits manipulation of cannabis derivatives

Submission of registrations, videos, and requests for confidentiality ends at 11:59 pm this Friday (5); item revising rules for cannabis products will be defined at the Dicol meeting on December 10

The item revising RDC 327/2019 reaches a decisive week at Anvisa, and the sector awaits to know if the topic will proceed to a vote or be postponed once again

Public call aims to gather scientific evidence to support the regulation of Cannabis cultivation for medicinal and pharmaceutical purposes in Brazil

Caroline Campagnone views RDC 999/2025 favorably, allowing veterinarians authorized by CFMV to prescribe medical cannabis

Preventive action involves imported and national items and reinforces rules for restricted disclosure to doctors and pharmacists

Measure published in the Official Gazette affects company; resolution prohibits sale of Cannabis products without sanitary registration

Anvisa's update "mirrors" the rules for controlling cannabis products directly in the list of controlled substances and defines classification for industrial inputs

The permission is exclusive for scientific research and follows strict control rules

Regulatory agency's approval includes adjustments in testing of products with shelf lives between 18 and 24 months manufactured by Prati-Donaduzzi and Promediol

Document presents preliminary guidelines for authorization of cultivation by legal entities and control mechanisms